These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 32562698)
1. Metabolic environment in vivo as a blueprint for differentiation and maturation of human stem cell-derived cardiomyocytes. Slaats RH; Schwach V; Passier R Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165881. PubMed ID: 32562698 [TBL] [Abstract][Full Text] [Related]
2. Maturation of human pluripotent stem cell derived cardiomyocytes in vitro and in vivo. Gomez-Garcia MJ; Quesnel E; Al-Attar R; Laskary AR; Laflamme MA Semin Cell Dev Biol; 2021 Oct; 118():163-171. PubMed ID: 34053865 [TBL] [Abstract][Full Text] [Related]
3. Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy. Tan SH; Ye L J Cardiovasc Transl Res; 2018 Oct; 11(5):375-392. PubMed ID: 29557052 [TBL] [Abstract][Full Text] [Related]
4. Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1α and LDHA. Hu D; Linders A; Yamak A; Correia C; Kijlstra JD; Garakani A; Xiao L; Milan DJ; van der Meer P; Serra M; Alves PM; Domian IJ Circ Res; 2018 Oct; 123(9):1066-1079. PubMed ID: 30355156 [TBL] [Abstract][Full Text] [Related]
5. Effective Hypothermic Storage of Human Pluripotent Stem Cell-Derived Cardiomyocytes Compatible With Global Distribution of Cells for Clinical Applications and Toxicology Testing. Correia C; Koshkin A; Carido M; Espinha N; Šarić T; Lima PA; Serra M; Alves PM Stem Cells Transl Med; 2016 May; 5(5):658-69. PubMed ID: 27025693 [TBL] [Abstract][Full Text] [Related]
7. Contractility of single cardiomyocytes differentiated from pluripotent stem cells depends on physiological shape and substrate stiffness. Ribeiro AJ; Ang YS; Fu JD; Rivas RN; Mohamed TM; Higgs GC; Srivastava D; Pruitt BL Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12705-10. PubMed ID: 26417073 [TBL] [Abstract][Full Text] [Related]
8. Metabolism-based cardiomyocytes production for regenerative therapy. Umei TC; Tohyama S; Fukuda K J Mol Cell Cardiol; 2023 Mar; 176():11-20. PubMed ID: 36681267 [TBL] [Abstract][Full Text] [Related]
9. Metabolomics Identifies Metabolic Markers of Maturation in Human Pluripotent Stem Cell-Derived Cardiomyocytes. Bhute VJ; Bao X; Dunn KK; Knutson KR; McCurry EC; Jin G; Lee WH; Lewis S; Ikeda A; Palecek SP Theranostics; 2017; 7(7):2078-2091. PubMed ID: 28656061 [TBL] [Abstract][Full Text] [Related]
10. Functional improvement and maturation of human cardiomyocytes derived from human pluripotent stem cells by barbaloin preconditioning. Yang H; Zhong W; Hamidi MR; Zhou G; Liu C Acta Biochim Biophys Sin (Shanghai); 2019 Sep; 51(10):1041-1048. PubMed ID: 31518384 [TBL] [Abstract][Full Text] [Related]
11. Learn from Your Elders: Developmental Biology Lessons to Guide Maturation of Stem Cell-Derived Cardiomyocytes. Marchianò S; Bertero A; Murry CE Pediatr Cardiol; 2019 Oct; 40(7):1367-1387. PubMed ID: 31388700 [TBL] [Abstract][Full Text] [Related]
12. Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes. Zhu R; Blazeski A; Poon E; Costa KD; Tung L; Boheler KR Stem Cell Res Ther; 2014 Oct; 5(5):117. PubMed ID: 25688759 [TBL] [Abstract][Full Text] [Related]
13. Promotion of maturation of human pluripotent stem cell-derived cardiomyocytes via treatment with the peroxisome proliferator-activated receptor alpha agonist Fenofibrate. Lee SG; Rhee J; Seok J; Kim J; Kim MW; Song GE; Park S; Jeong KS; Lee S; Lee YH; Jeong Y; Kim CY; Chung HM Stem Cells Transl Med; 2024 Aug; 13(8):750-762. PubMed ID: 38946019 [TBL] [Abstract][Full Text] [Related]
14. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells. Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653 [TBL] [Abstract][Full Text] [Related]
15. Advancing Cardiovascular Drug Screening Using Human Pluripotent Stem Cell-Derived Cardiomyocytes. Oh J; Kwon OB; Park SW; Kim JW; Lee H; Kim YK; Choi EJ; Jung H; Choi DK; Oh BJ; Min SH Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063213 [TBL] [Abstract][Full Text] [Related]
16. Functional maturation of human pluripotent stem cell derived cardiomyocytes in vitro--correlation between contraction force and electrophysiology. Ribeiro MC; Tertoolen LG; Guadix JA; Bellin M; Kosmidis G; D'Aniello C; Monshouwer-Kloots J; Goumans MJ; Wang YL; Feinberg AW; Mummery CL; Passier R Biomaterials; 2015 May; 51():138-150. PubMed ID: 25771005 [TBL] [Abstract][Full Text] [Related]
17. Enhancing Maturation and Translatability of Human Pluripotent Stem Cell-Derived Cardiomyocytes through a Novel Medium Containing Acetyl-CoA Carboxylase 2 Inhibitor. Correia C; Christoffersson J; Tejedor S; El-Haou S; Matadamas-Guzman M; Nair S; Dönnes P; Musa G; Rohman M; Sundqvist M; Riddle RB; Nugraha B; Bellido IS; Johansson M; Wang QD; Hidalgo A; Jennbacken K; Synnergren J; Später D Cells; 2024 Aug; 13(16):. PubMed ID: 39195229 [TBL] [Abstract][Full Text] [Related]
18. Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform. Denning C; Borgdorff V; Crutchley J; Firth KS; George V; Kalra S; Kondrashov A; Hoang MD; Mosqueira D; Patel A; Prodanov L; Rajamohan D; Skarnes WC; Smith JG; Young LE Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1728-48. PubMed ID: 26524115 [TBL] [Abstract][Full Text] [Related]
19. Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice. Lou X; Tang Y; Ye L; Pretorius D; Fast VG; Kahn-Krell AM; Zhang J; Zhang J; Qiao A; Qin G; Kamp T; Thomson JA; Zhang J Cardiovasc Res; 2023 May; 119(4):1062-1076. PubMed ID: 36647784 [TBL] [Abstract][Full Text] [Related]
20. The Aurora Kinase Inhibitor CYC116 Promotes the Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells. Ji S; Tu W; Huang C; Chen Z; Ren X; He B; Ding X; Chen Y; Xie X Mol Cells; 2022 Dec; 45(12):923-934. PubMed ID: 36572561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]